Skip to main content
. 2017 Aug 11;10(9):661–671. doi: 10.1177/1756283X17722915

Table 5.

Kappa (SE) between the different methods using different cut-offs.

Cut-off 3 μg/ml 4 μg/ml 5 μg/ml 6 μg/ml 7 μg/ml 8 μg/ml 9 μg/ml 10 μg/ml
In-house
 Sanquin 0.774 (0.046) 0.748 (0.049) 0.6961 (0.054) 0.660 (0.058) 0.636 (0.060) 0.6161 (0.063) 0.582 (0.066) 0.615 (0.065)
 QB 0.891 (0.034) 0.806 (0.043) 0.738 (0.050) 0.696 (0.053) 0.655 (0.057) 0.630 (0.060) 0.624 (0.062) 0.601 (0.064)
 R-Biopharm 0.835 (0.041) 0.732 (0.049) 0.753 (0.047) 0.687 (0.051) 0.699 (0.053) 0.636 (0.057) 0.629 (0.058) 0.660 (0.058)
Sanquin
 QB 0.753 (0.047) 0.711 (0.050) 0.711 (0.059) 0.774 (0.047) 0.815 (0.044) 0.8198 (0.044) 0.823 (0.045) 0.817 (0.047)
 R-Biopharm 0.744 (0.047) 0.684 (0.050) 0.684 (0.050) 0.676 (0.052) 0.691 (0.052) 0.702 (0.052) 0.721 (0.051) 0.742 (0.052)
QB
 R-Biopharm 0.901 (0.032) 0.902 (0.032) 0.860 (0.037) 0.849 (0.038) 0.847 (0.039) 0.832 (0.041) 0.771 (0.048) 0.747 (0.051)

QB, Quantum Blue® Infliximab: Quantitative Lateral Flow Assay (Bühlmann, Schönenbuch, Switzerland); SE, standard error.